Stock Price
2,222.00
Daily Change
27.40 1.25%
Monthly
3.26%
Yearly
1.64%
Q1 Forecast
2,110.61

Lupin reported INR70.48B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Bharat Petroleum INR 1.09T 0 Dec/2025
Cipla INR 75.18B 710M Dec/2025
Divis Laboratories Ltd INR 27.15B 3.05B Sep/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
UPL INR 123.61B 3.42B Dec/2025